151 related articles for article (PubMed ID: 16835505)
1. Modeling the effect of tamoxifen chemoprevention on long-term mortality in white women at high risk of breast cancer.
Maucort-Boulch D; Roy P
Eur J Cancer Prev; 2006 Aug; 15(4):347-52. PubMed ID: 16835505
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials.
Vogel VG; Costantino JP; Wickerham DL; McCaskill-Stevens W; Clarfeld RB; Grant MD; Wolmark N
J Natl Cancer Inst Monogr; 2010; 2010(41):181-6. PubMed ID: 20956826
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
Fisher B; Costantino JP; Wickerham DL; Redmond CK; Kavanah M; Cronin WM; Vogel V; Robidoux A; Dimitrov N; Atkins J; Daly M; Wieand S; Tan-Chiu E; Ford L; Wolmark N
J Natl Cancer Inst; 1998 Sep; 90(18):1371-88. PubMed ID: 9747868
[TBL] [Abstract][Full Text] [Related]
6. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
Cuzick J; Forbes J; Edwards R; Baum M; Cawthorn S; Coates A; Hamed A; Howell A; Powles T;
Lancet; 2002 Sep; 360(9336):817-24. PubMed ID: 12243915
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
[TBL] [Abstract][Full Text] [Related]
8. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
9. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of using a genetic test to direct breast cancer chemoprevention in white women with a previous breast biopsy.
Green LE; Dinh TA; Hinds DA; Walser BL; Allman R
Appl Health Econ Health Policy; 2014 Apr; 12(2):203-17. PubMed ID: 24595521
[TBL] [Abstract][Full Text] [Related]
12. Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.
Kennecke HF; Olivotto IA; Speers C; Norris B; Chia SK; Bryce C; Gelmon KA
Ann Oncol; 2007 Jan; 18(1):45-51. PubMed ID: 17030545
[TBL] [Abstract][Full Text] [Related]
13. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.
Freedman AN; Graubard BI; Rao SR; McCaskill-Stevens W; Ballard-Barbash R; Gail MH
J Natl Cancer Inst; 2003 Apr; 95(7):526-32. PubMed ID: 12671020
[TBL] [Abstract][Full Text] [Related]
14. From adjuvant therapy to breast cancer prevention: BCPT and STAR.
Dunn BK; Ford LG
Breast J; 2001; 7(3):144-57. PubMed ID: 11469927
[TBL] [Abstract][Full Text] [Related]
15. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.
Dignam JJ; Wieand K; Johnson KA; Fisher B; Xu L; Mamounas EP
J Natl Cancer Inst; 2003 Oct; 95(19):1467-76. PubMed ID: 14519753
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial.
Wickerham DL
Recent Results Cancer Res; 2003; 163():87-95; discussion 264-6. PubMed ID: 12903845
[TBL] [Abstract][Full Text] [Related]
17. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
[TBL] [Abstract][Full Text] [Related]
18. Survival impact of tamoxifen use for breast cancer risk reduction: projections from a patient-specific Markov model.
Col NF; Goldberg RJ; Orr RK; Erban JK; Fortin JM; Chlebowski RT
Med Decis Making; 2002; 22(5):386-93. PubMed ID: 12365480
[TBL] [Abstract][Full Text] [Related]
19. Long-term comparisons of the efficacy, safety, and pregnancy outcomes of adjuvant tamoxifen plus ovarian function suppression in premenopausal Han and Zhuang Chinese patients with hormone receptor-positive early breast cancer.
Tang S; Zhang Q; Tang X; Chen D; Zhang F; Liu J; Wei W; Liu D
J Int Med Res; 2019 Feb; 47(2):641-652. PubMed ID: 30354917
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
Vogel VG
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]